These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study. Varma VR; Oommen AM; Varma S; Casanova R; An Y; Andrews RM; O'Brien R; Pletnikova O; Troncoso JC; Toledo J; Baillie R; Arnold M; Kastenmueller G; Nho K; Doraiswamy PM; Saykin AJ; Kaddurah-Daouk R; Legido-Quigley C; Thambisetty M PLoS Med; 2018 Jan; 15(1):e1002482. PubMed ID: 29370177 [TBL] [Abstract][Full Text] [Related]
7. Metabolomics in early Alzheimer's disease: identification of altered plasma sphingolipidome using shotgun lipidomics. Han X; Rozen S; Boyle SH; Hellegers C; Cheng H; Burke JR; Welsh-Bohmer KA; Doraiswamy PM; Kaddurah-Daouk R PLoS One; 2011; 6(7):e21643. PubMed ID: 21779331 [TBL] [Abstract][Full Text] [Related]
8. Absolute quantitative lipidomics reveals lipidome-wide alterations in aging brain. Tu J; Yin Y; Xu M; Wang R; Zhu ZJ Metabolomics; 2017 Nov; 14(1):5. PubMed ID: 30830317 [TBL] [Abstract][Full Text] [Related]
9. Lipidomic alterations in lipoproteins of patients with mild cognitive impairment and Alzheimer's disease by asymmetrical flow field-flow fractionation and nanoflow ultrahigh performance liquid chromatography-tandem mass spectrometry. Kim SH; Yang JS; Lee JC; Lee JY; Lee JY; Kim E; Moon MH J Chromatogr A; 2018 Sep; 1568():91-100. PubMed ID: 30007793 [TBL] [Abstract][Full Text] [Related]
10. Concordant peripheral lipidome signatures in two large clinical studies of Alzheimer's disease. Huynh K; Lim WLF; Giles C; Jayawardana KS; Salim A; Mellett NA; Smith AAT; Olshansky G; Drew BG; Chatterjee P; Martins I; Laws SM; Bush AI; Rowe CC; Villemagne VL; Ames D; Masters CL; Arnold M; Nho K; Saykin AJ; Baillie R; Han X; Kaddurah-Daouk R; Martins RN; Meikle PJ Nat Commun; 2020 Nov; 11(1):5698. PubMed ID: 33173055 [TBL] [Abstract][Full Text] [Related]
11. Integrative Lipidomics and Metabolomics for System-Level Understanding of the Metabolic Syndrome in Long-Term Treated HIV-Infected Individuals. Olund Villumsen S; Benfeitas R; Knudsen AD; Gelpi M; Høgh J; Thomsen MT; Murray D; Ullum H; Neogi U; Nielsen SD Front Immunol; 2021; 12():742736. PubMed ID: 35095835 [TBL] [Abstract][Full Text] [Related]
12. Unbiased Metabolomic Investigation of Alzheimer's Disease Brain Points to Dysregulation of Mitochondrial Aspartate Metabolism. Paglia G; Stocchero M; Cacciatore S; Lai S; Angel P; Alam MT; Keller M; Ralser M; Astarita G J Proteome Res; 2016 Feb; 15(2):608-18. PubMed ID: 26717242 [TBL] [Abstract][Full Text] [Related]
13. Plasma lipidome is dysregulated in Alzheimer's disease and is associated with disease risk genes. Liu Y; Thalamuthu A; Mather KA; Crawford J; Ulanova M; Wong MWK; Pickford R; Sachdev PS; Braidy N Transl Psychiatry; 2021 Jun; 11(1):344. PubMed ID: 34092785 [TBL] [Abstract][Full Text] [Related]
14. Serum Metabolomic and Lipidomic Profiling Reveals Novel Biomarkers of Efficacy for Benfotiamine in Alzheimer's Disease. Bhawal R; Fu Q; Anderson ET; Gibson GE; Zhang S Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34947984 [TBL] [Abstract][Full Text] [Related]
15. Integrated lipidomics and proteomics network analysis highlights lipid and immunity pathways associated with Alzheimer's disease. Xu J; Bankov G; Kim M; Wretlind A; Lord J; Green R; Hodges A; Hye A; Aarsland D; Velayudhan L; Dobson RJB; Proitsi P; Legido-Quigley C; Transl Neurodegener; 2020 Sep; 9(1):36. PubMed ID: 32951606 [TBL] [Abstract][Full Text] [Related]
18. Nutritional Lipidomics in Alzheimer's Disease. Kalli E Adv Exp Med Biol; 2020; 1195():95-104. PubMed ID: 32468464 [TBL] [Abstract][Full Text] [Related]
19. Alzheimer's Disease Risk Genes and Lipid Regulators. El Gaamouch F; Jing P; Xia J; Cai D J Alzheimers Dis; 2016 Apr; 53(1):15-29. PubMed ID: 27128373 [TBL] [Abstract][Full Text] [Related]
20. A Community-Based Study Identifying Metabolic Biomarkers of Mild Cognitive Impairment and Alzheimer's Disease Using Artificial Intelligence and Machine Learning. Yilmaz A; Ustun I; Ugur Z; Akyol S; Hu WT; Fiandaca MS; Mapstone M; Federoff H; Maddens M; Graham SF J Alzheimers Dis; 2020; 78(4):1381-1392. PubMed ID: 33164929 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]